Reaction of methyl 2-aryl-5-(chlorosulfonyl)-1,3-oxazole-4-carboxylates with 1H-pyrazol-5-amines and 1H-1,2,4-triazol-5-amines proceeds with the participation of endocyclic aminoazole nitrogen atoms to yield products containing a primary amino group. Being treated by sodium hydride these products undergo a further transformation into the tricyclic compounds. It has been shown that the cyclocondensation pathway includes the Smiles rearrangement with extrusion of SO2 followed by the elimination of MeOH. This reaction sequence is a convenient approach to the synthesis of new annulated [1, 3] oxazolo [5,4-d]pyrimidine derivatives.
Introduction
Among a variety of pharmaceutically promising amides of azolesulfonic acids, oxazolesulfonyl amides seem to us particularly interesting. These species have the weakly aromatic oxazole ring capable to hydrolytic cleavage, 1 which may be important for bioactivity associated with the enzyme inhibition. Thus, 1,3-oxazole-5-sulfonyl amide 1 ( Fig. 1) is known to be a rare dual cyclooxygenase-2/5-lipoxygenase inhibitor. Other promising representatives of 1,3-oxazole-5-sulfonyl amides are those bearing a pronounced electron-withdrawing substituent at position C(4), in particular, compounds 2 and 3 obtained recently from the corresponding 1,5-oxazole 5-sulfonyl chlorides in our laboratory. 3, 4 One of our research tasks was entering into the sulfonamide grouping of 2 and 3 an electron-deficient heterocyclic substituent R 2 , which increases the acidity of the N-H linkage making a molecule to be easier delivered to the target enzyme like that in the case of the sulfanilamide drugs. 5 Recently we reported that the interaction of 4-cyano-1,3-oxazole-5-sulfonyl chlorides with 1H-pyrazol-5-amines and 1H-1,2,4-triazol-5-amine leads to unexpected substitution products, which, nevertheless, are useful for further heterocyclization. 6 The aim of the present work was to investigate into products of interaction of 1,3-oxazole-5-sulfonyl chlorides having a methoxycarbonyl group at position C(4) with the aforementioned heterocyclic amines.
Results and Discussion
Methyl 2-aryl-5-(chlorosulfonyl)-1,3-oxazole-4-carboxylates 4 were treated with commercially available 1H-pyrazol-5-amines 5 and 1H-1,2,4-triazol-5-amines 6 in the conditions shown in Scheme 1.
Scheme 1. Synthesis of compounds 7 and 8
Despite the fact that a very similar analogy was reported with this reaction, 6 its result requires careful consideration because both endo-and exocyclic aminoazole nitrogen atoms can take part. It is known, for example, that 3-metyl-1H-pyrazol-5-amine as well as 3-metyl-1H-1,2,4-triazol-5-amine react with aromatic sulfonyl chlorides to give mixtures of sulfonyl derivatives. 7, 8 Nevertheless, the reaction of 4 with 5 and 6 in the presence of triethylamine proceeded quite regioselectively with 76-84% yield of endo-substitution products 7 and 8. The fact that compounds 7 and 8 contain a primary amino group is confirmed by i) two characteristic IR absorption bands relevant to the asymmetric and symmetric N-H stretching from 3500-3200 cm -1 , ii) a two proton NMR singlet at 6.5 ppm (for 7) and within 7.8-7.5 ppm (for 8). X-ray crystal analysis of 7c and 8b was also carried out, which revealed their additional structural stabilization due to an intramolecular NH2···O2S hydrogen bond ( Fig. 2 and Fig. 3 ).
Fig. 2. ORTEP diagram of solvate 7c·MeCN with 50% ellipsoids probability
In molecule 7c, the 1,3-oxazole and the pyrazole ring mean planes make a dihedral angle of 80.60(9)°. Benzene ring C(4)-C(9) and the CO2Me group are rotated relative to the 1,3-oxazole ring by 13.67(15) and 29.75(16)º, respectively. Intramolecular N(4)H···O(5) hydrogen bond was found with the following parameters N(4)-H 0.83(3) Å, N(4)···O(5) 2.807(3) Å, N(4)HO(5) 133(2)º. Our recent investigations showed that analogues of products 7 and 8 bearing a CN group instead of CO2Me at C(4) of the 1,3-oxazole ring when treated by sodium hydride undergo a transformation into tricyclic compounds.
6 Scheme 2 demonstrates how compounds 7 and 8 have been involved in a similar cyclocondensation to provide fused heterocycles 9 and 10.
Scheme 2. Formation of compounds 9 and 10
As for the mechanism, anion-intermediates A-D are conceived, from which sequence A-C is a new example of the N -S Smiles rearrangement with the sulfur dioxide extrusion. 9 Products 9 and 10 were obtained in 60-75% yield and are very high melted and poorly soluble solids. Their structure was verified by the spectral data, among which it is worth mentioning the strong IR absorption in the region 1680-1720 cm -1 attributed to C=O bond vibration. This characteristic allows excluding the existence of 9 and 10 in the OH tautomer form in the solid state. However, they can exist in different NH tautomer forms (9, 9' and 10, 10', 10"). X-ray diffraction study of compound 10c showed that the [1, 3] oxazolo [5,4-d] [1, 2, 4] triazolo [1,5-a] pyrimidin-9(5H)-one structure 10" takes place in a crystal (Fig. 4) . We did not study the tautomerism in a solution. In the 1 H NMR spectra of 9 and 10 dissolved in DMSO-d6, the NH signal was not detected but multiplets analysis indicated the presence of the only tautomer. (3) 168(2)º.
It should be noted that the elimination of MeOH is, apparently, a rate-determining stage of the transformation A→D. We found that if compounds 7b,c are heated with NaH in THF for only 30 min, the Smiles rearrangement products 11b,c are allowed to be isolated in 62-65% yield after acidifying the reaction mixture (Scheme 3, one of the two possible tautomers of 11 is shown). These later cyclize into 9b,c on further heating with NaH in THF. This observation along with the above crystallographic evidence supports the cyclocondensation pathway shown in Scheme 2 and doubts on the alternative possibility depicted in Scheme 4.
Scheme 4. An alternative cyclocondensation pathway
Theoretically anions A could eliminate MeOH to give 7 membered cyclic intermediates E. An analogy of this cyclization has been reported. 10 Anions E could undergo ring contraction to give anions F. The protonation of the latter could lead to the angular regioisomers of tricyclic compounds 8 and 9, which in fact were not found during the experiment.
Conclusion
In conclusion, described in the article cyclocondensation reaction of esters 7 and 8 under the action of NaH the Smiles rearrangement with extrusion of SO2 does occur followed by the elimination of MeOH. This reaction sequence is a convenient approach to the synthesis of new "a" annulated [1, 3] oxazolo [5,4-d] pyrimidine derivatives.
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Experimental

Instruments, Reagents, and Methods
Melting points were determined on a Fisher-Johns apparatus. IR spectra were recorded on a Vertex-70 spectrometer from KBr pellets.
1 H and 13 C NMR spectra were recorded on Varian Mercury 400 (400 and 100 MHz, respectively) and Bruker Avance DRX 500 (500 and 125 MHz, respectively) spectrometers in DMSO-d6.
13 C NMR spectra were obtained for most new compounds, except for 9a-c and 10a,b because of their poor solubility. LC-MS analysis was performed on an Agilent 1200 Series system equipped with a diode array and a G6130A mass-spectrometer (atmospheric pressure electrospray ionization). Combustion elemental analysis was performed in the Institute of Bioorganic Chemistry and Petrochemistry analytical laboratory.
Crystallographic measurements were performed on a Bruker Smart Apex II diffractometer operating in the  scan mode using Mo-K radiation with  = 0.71078 Å. Structures were solved by direct methods and refined by the full-matrix least-squares technique in the anisotropic approximation for non-hydrogen atoms using the Bruker SHELXTL program package. 11 The carbon-linked hydrogen atoms were placed at calculated positions and refined as a "riding" model, the other hydrogen atoms were located in DF synthesis and refined isotropically. Crystallographic data (excluding structure factors) for the structures in this paper have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication numbers CCDC1834792, CCDC1834794, and CCDC1834796. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, (fax: +44-(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.Uk). 
Experimental procedure and physical data for compounds 7 and 8
Compound 4 (4 mmol) was added to a solution of heterocyclic amine 5 or 6 (4 mmol) and Et3N (4 mmol) in anhydrous dioxane (15 mL), this composition was refluxed for 2 h. The resulting mixture was cooled to 20-25 °C, the precipitate was filtered off, and the filtrate was evaporated in vacuum. The residue was triturated with water to give a crude product which was separated, recrystallized from MeCN, and dried at 70-80 °C. amino-3-phenyl-1H-pyrazol-1-yl) 5-amino-3-(4-methylphenyl)-1H-pyrazol-1-yl)sulfonyl)-2-phenyl-1,3-oxazole-4 5-amino-3-phenyl-1H-pyrazol-1-yl)sulfonyl)-2-(4-methylphenyl)-1,3- , Z = 2, dc = 1.512 g·cm -3 ,  = 0.233 мм -1 , F(000) = 398. Intensities were measured at 173K within max  27.8 (10099 reflections total, 3826 unique reflections, Rmerg = 0.0415). The convergence was obtained at R1 = 0.0549, wR2 = 0.1337 for 2621 observed reflections with I  (I) and at R1 = 0.0919, wR2 = 0.1506, GOF = 1.067 for 3826 independent reflections, 247 parameters, the maximum and minimum peaks on the final difference map correspond to 0.58 and -0.49 e/Å 3 . amino-3-phenyl-1H-1,2,4-triazol-1-yl)sulfonyl)-2-(4-methylphenyl)-1,3- 
Methyl 5-((5-
Methyl 5-((
Methyl 5-((5-amino-3-phenyl-1H-1,2,4-triazol-1-yl)sulfonyl)-2-phenyl-1,3-oxazole-4-carboxylate (8a)
Methyl 5-((5-amino-1H-1,2,4-triazol-1-yl)sulfonyl)-2-(4-methylphenyl)-1,3-oxazole-4-carboxylate (8b)
Methyl 5-((5-
Experimental procedure and physical data for compounds 9
To a solution of compound 7 or 11 (1 mmol) in anhydrous THF (15 mL), 80 mg of 60% NaH (2 mmol) was added. The reaction mixture was stirred at 20-25 °C for 1 h then heated at 50-60 °C for 2 h, cooled to room temperature, diluted with water (20 mL), and acidified by the concd hydrochloric acid (0.2 mL). The precipitate formed was filtered off, recrystallized from DMF/MeCN (1:1), and dried at 70-80 °C to give the analytically pure product. [1, 3] oxazolo [5,4-d] pyrazolo [1,5- 
2,6-Diphenyl
a]pyrimidin-9(4H)-one (9a)
Colorless solid; 67% yield; mp above 300 °C. IR, ν, cm -1 : 3400-2650 (NH, CH), 1689 (C=O). [1, 3] oxazolo [5,4-d] pyrazolo [1,5-a] [1, 3] oxazolo [5,4-d] pyrazolo [1,5-a] 
6-(4-Methylphenyl)-2-phenyl
2-(4-Methylphenyl)-6-phenyl
pyrimidin-9(4H)-one (9c)
Light yellow solid; 62% (from 7c), 69% (from 11c) yield; mp above 300 °C. IR, ν, cm 
Experimental procedure and physical data for compounds 10
To a solution of compound 8 (1 mmol) in anhydrous THF (15 mL), 80 mg of 60% NaH (2 mmol) was added. The reaction mixture was stirred at 20-25 °C for 1 h then heated at 50-60 °C for 2 h, cooled to room temperature, diluted with water (20 mL), and acidified by the concd hydrochloric acid (0.2 mL). The precipitate formed was filtered off, recrystallized from DMF/MeCN (1:1), and dried at 70-80 °C to give the analytically pure product. [1, 3] oxazolo [5,4-d] [1, 2, 4] triazolo [1,5-a] [1, 3] oxazolo [5,4-d] [1, 2, 4] triazolo [1,5-a] [1, 3] oxazolo [5,4-d] [1, 2, 4] triazolo [1,5-a] 
2,6-Diphenyl
2-(4-Methylphenyl)
2-(4-Methylphenyl)-6-phenyl
Experimental procedure and physical data for compounds 11
To a solution of one of compounds 7b,c (1 mmol) in anhydrous THF (15 mL), 80 mg of 60% NaH (2 mmol) was added. The reaction mixture was stirred at 20-25 °C for 1 h then heated at 50-60 °C for 30 min, cooled to room temperature, diluted with water (20 mL), and acidified by the concd hydrochloric acid (0.2 mL). The precipitated product was filtered off, recrystallized from MeCN, and dried at 70-80 °C. 
Methyl 5-((3-(4-methylphenyl)-1H-pyrazol-5-yl)amino)-2-phenyl-1,3-oxazole-4-carboxylate (11b)
